Literature DB >> 10620562

Rapidly progressive renal failure with nephrotic syndrome in a patient with type 2 diabetes mellitus: the differential of fibrillary deposits.

C Ovuworie1, K Volmar, D Charney, S Kravet, L Racusen.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10620562     DOI: 10.1016/S0272-6386(00)70319-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  6 in total

1.  Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus.

Authors:  Ipek Isik Gonul; James Gough; Kim Jim; Hallgrimur Benediktsson
Journal:  Int Urol Nephrol       Date:  2007-01-09       Impact factor: 2.370

Review 2.  Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).

Authors:  Nattawat Klomjit; Mariam Priya Alexander; Ladan Zand
Journal:  Kidney360       Date:  2020-07-08

3.  Fibrillary glomerulonephritis: presenting as crescentic glomerulonephritis causing rapidly progressive renal failure.

Authors:  Shalini Nilajgi; John Paul Killen; Richard Baer; Patricia Renaut; Murty Mantha
Journal:  NDT Plus       Date:  2011-12

4.  Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis.

Authors:  H H Shah; J Thakkar; J M Pullman; A T Mathew
Journal:  Indian J Nephrol       Date:  2017 Mar-Apr

5.  The occurrence or fibrillary glomerulonephritis in patients with diabetes mellitus may not be coincidental: a report of four cases.

Authors:  Fayna González-Cabrera; Fernando Henríquez-Palop; Ana Ramírez-Puga; Raquel Santana-Estupiñán; Celia Plaza-Toledano; Gloria Antón-Pérez; Silvia Marrero-Robayna; Davinia Ramírez-Medina; Roberto Gallego-Samper; Nicanor Vega-Díaz; Rafael Camacho-Galan; José C Rodríguez-Pérez
Journal:  Case Rep Med       Date:  2013-05-20

6.  Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy.

Authors:  Muhammad M Javaid; Helen Denley; Senyo Tagboto
Journal:  BMC Nephrol       Date:  2007-05-09       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.